Pfizer Doesn't Owe Attorneys' Fees, Court Says

Law360, New York (June 26, 2007, 12:00 AM EDT) -- Pfizer Inc. does not have to pay attorneys' fees to plaintiffs after it tried to remove the class action from state to federal court, an appeals court has ruled, overturning a district judge's award to a group of people who sued the drug maker for its marketing of anti-inflammatory painkillers Bextra and Celebrex.

Following Pfizer's failed attempt to remove the lawsuit from a state court to the Southern District of Illinois—a motion that cited the Class Action Fairness Act—plaintiffs were granted about $23,600 in attorneys' fees...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.